Hospital Virgen de la Arrixaca -ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2022

  1. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

    Journal of Personalized Medicine, Vol. 12, Núm. 7

2018

  1. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 48, Núm. 6

2015

  1. CALU polymorphism A29809G affects calumenin availability involving vascular calcification

    Journal of Molecular and Cellular Cardiology, Vol. 82, pp. 218-227

2014

  1. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 781-788

2010

  1. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

    Annals of Medicine, Vol. 42, Núm. 6, pp. 439-446

  2. Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

    Thrombosis Research, Vol. 126, Núm. 1

2009

  1. Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486

  2. Implications of pharmacogenetics for oral anticoagulants metabolism

    Current Drug Metabolism, Vol. 10, Núm. 6, pp. 632-642

  3. Pharmacogenetics in Cardiovascular Antithrombotic Therapy

    Journal of the American College of Cardiology, Vol. 54, Núm. 12, pp. 1041-1057

2008

  1. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

2004

  1. Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage

    Stroke, Vol. 35, Núm. 10, pp. 2282-2286

2003

  1. Polymorphisms of platelet adhesive receptors: Do they play a role in primary intracerebral hemorrhage?

    Cerebrovascular Diseases, Vol. 15, Núm. 1-2, pp. 51-55

2001

  1. Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage

    Blood, Vol. 97, Núm. 10, pp. 2979-2982

2000

  1. Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage

    Hematology Journal, Vol. 1, Núm. 4, pp. 269-273